PharmEasy Unlisted Share
₹5.6▼13.85%(0.90)
About the company
PharmEasy is an Indian digital healthcare platform that provides access to medicines, healthcare products, diagnostic tests, and other health-related services through its online platform. Founded in 2015 by Dharmil Sheth and Dr. Dhaval Shah, the company was created with the aim of making healthcare more accessible and convenient for consumers.
Through its technology-driven platform and healthcare network, PharmEasy connects customers with pharmacies, diagnostic services, and other healthcare providers, offering a convenient way to access a range of healthcare products and services across India.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | ₹7.75 |
| 52 week low | ₹5.6 |
| P/B ratio | 0 |
| Debt to equity | N/A |
| ROE (%) | N/A |
| Book value | N/A |
| Face value | ₹1 |
52 week high
52 week low
| Metric | Value |
|---|---|
| 52 week high | ₹7.75 |
| 52 week low | ₹5.6 |
Registry
| Metric | Value |
|---|---|
| ISIN number | INE0DJ201029 |
Figures in cr ·
Financials
| P&L Statement | 2025Latest | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 5872 | 5664 | 6644 | 5729 |
| EBITDA | -661 | -646 | -1421 | -2345 |
| OPM | -11.26 | -11.41 | -21.39 | -40.93 |
| PBT | -1517 | -2522 | -5196 | -3977 |
| PAT | -1572 | -2533 | -5211 | -3999 |
| EPS | -2.26 | -3.9 | -8.48 | -6.51 |
Shareholding Pattern
Naspers Ventures B. V
MacRitchie Investments Pte. Ltd.
TPG Growth V SF Markets Pte. Ltd.
Evermed Holding Pte. Ltd
Others
| Holder | Percentage |
|---|---|
| Naspers Ventures B. V | 12.48% |
| MacRitchie Investments Pte. Ltd. | 11.24% |
| TPG Growth V SF Markets Pte. Ltd. | 6.90% |
| Evermed Holding Pte. Ltd | 6.08% |
| Others | 63.30% |
Leadership
Frequently asked questions
Common questions on PharmEasy Unlisted Share—tap a row to read the answer.
Q.1How can I buy PharmEasy Unlisted Shares?
If you're interested in buying PharmEasy unlisted shares, you generally need an active Demat account, PAN, bank account, and completed KYC. You can start by checking the current share price and availability in the unlisted market.
Once the price and quantity are agreed upon, you can complete the payment as per the transaction terms. After settlement, the shares are transferred to your Demat account. Before investing, take time to understand the company's financial performance, valuation, business prospects, and the risks involved.
Q.2How can I sell PharmEasy Unlisted Shares?
If you already own PharmEasy shares and want to sell them, you can check the current buying price and demand in the unlisted market. Once you agree on the price and quantity with a buyer, the shares can be transferred from your Demat account.
Payment is completed according to the agreed settlement process. Since these shares are not traded on a regular stock exchange, the selling price and liquidity may vary based on market conditions and buyer interest.
Q.3What is the lock-in period for PharmEasy Unlisted Shares?
Before a public listing, the shares can generally be bought and sold in the unlisted market, subject to any applicable transfer restrictions.
If PharmEasy comes out with an IPO in the future, shares acquired before the IPO may be subject to a post-listing lock-in period under the SEBI regulations applicable at that time. Investors should check the latest rules before investing or planning to sell their holdings.
Q.4How is DIS used to sell PharmEasy Unlisted Shares?
A Delivery Instruction Slip (DIS) is one way to transfer shares from your Demat account to the buyer's Demat account. It generally requires details such as the ISIN, number of shares, and recipient's Demat account information.
The completed DIS is submitted to your Depository Participant (DP) to initiate the transfer. Some DPs may also offer an electronic transfer option. Always verify the details carefully before authorizing a transaction.
Q.5What is the minimum investment required to buy PharmEasy Unlisted Shares?
The minimum investment amount depends on the current PharmEasy unlisted share price and the minimum quantity available for purchase.
Since the price and availability of shares can change over time, there may not always be a fixed minimum ticket size. It is best to check the current price, available quantity, and total investment amount before proceeding with a purchase.
Q.6Is buying PharmEasy Unlisted Shares legal in India?
Yes, buying and selling shares of an unlisted company is generally legal in India, provided the transaction is carried out in accordance with applicable laws and regulations.
Investors should complete the necessary KYC requirements, use valid bank and Demat accounts, and maintain proper records of their transactions. It is also important to conduct proper due diligence before investing.
Q.7How are short-term capital gains on PharmEasy Unlisted Shares taxed?
If you sell your shares within the holding period classified as short-term under prevailing Indian tax laws, any profit earned may be treated as a Short-Term Capital Gain (STCG).
The applicable tax treatment depends on the tax rules in effect at the time of sale and your individual circumstances. Since tax regulations may change, consider consulting a qualified tax professional for guidance specific to your situation.
Q.8How are long-term capital gains on PharmEasy Unlisted Shares taxed?
If the shares are held for the required period to qualify as a long-term capital asset before being sold, any profit earned may be treated as a Long-Term Capital Gain (LTCG).
The applicable tax rate and treatment depend on the income-tax regulations in force at the time of sale. Investors should maintain proper records of the purchase date, acquisition cost, and sale transaction for accurate tax calculation and filing.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

Unlisted Shares Price List India | Buy Pre IPO Shares Online
The Unlisted Shares Price List India helps investors track the latest prices of privately traded companies before they are listed on stock exchanges. This guide explains what Unlisted Shares and Pre IPO Shares are, how their prices are determined, and the factors that influence their valuation. It also covers the benefits, risks, taxation, and step-by-step process of buying unlisted shares in India. Additionally, the article highlights popular companies such as NSE India, OYO, API Holding (Pharm Easy), MSEI, Gamma Rotors, Zepto, Orbis Financial, and Motilal Oswal Home Finance, providing readers with a comprehensive understanding of India's growing pre-IPO market. Whether you're a new or experienced investor, this guide offers practical insights to help you make informed investment decisions.

NSE IPO Moves Closer: SEBI Approval Expected by Mid-August, Listing May Happen in September
The National Stock Exchange (NSE) IPO is moving closer to listing, with SEBI's approval for the IPO draft expected by mid-August 2026, according to NDTV Profit sources. If the remaining regulatory process is completed on time, NSE could be listed in September 2026, subject to final approvals and market conditions. A key development is the expected final settlement order in the NSE co-location case, with the settlement amount likely to exceed ₹1,400 crore. Meanwhile, NSE has reportedly begun domestic and international investor roadshows as part of its IPO preparations. While these updates indicate strong momentum toward the IPO, the final timeline remains subject to SEBI approval and official announcements.

NCDEX Launches 'Nidhi' Mutual Fund Platform: A New Chapter in India's Financial Inclusion Journey
NCDEX has launched the 'Nidhi' Mutual Fund Platform, marking a significant step toward expanding financial inclusion across rural and semi-urban India. The platform aims to simplify mutual fund investments by leveraging NCDEX's extensive FPO and agri-network, making investment opportunities more accessible to underserved communities. With six leading Asset Management Companies (AMCs) onboard at launch, the initiative seeks to encourage wider participation in India's mutual fund ecosystem and promote long-term wealth creation. Discover the key features, benefits, and potential impact of the NCDEX Nidhi Mutual Fund Platform, and learn how this strategic move strengthens NCDEX's presence beyond commodity markets while supporting the growth of India's financial ecosystem.

AirLife Gases Business Model, Growth Strategy & Valuation: A Complete Analysis
AirLife Gases is emerging as a key player in India's specialty gas industry with a strong focus on helium supply, infrastructure, and global expansion. Explore its business model, valuation, growth strategy, financial outlook, and the potential of AirLife Gases unlisted shares.

Why Sustainable Investing in Unlisted Shares is Becoming the Smart Choice for Indians
Sustainable investing in unlisted shares is becoming an increasingly popular choice among Indian investors who want to combine long-term wealth creation with responsible investing. By investing in high-growth private companies that follow strong Environmental, Social, and Governance (ESG) practices, investors can support innovation while potentially earning attractive returns. Although unlisted shares involve risks such as lower liquidity and valuation challenges, careful research, diversification, and a long-term investment approach can help manage these risks. If you're looking to invest in unlisted shares, visit Dhankirti.co.in to explore trusted investment opportunities and expert guidance.

Risks and Rewards of Investing in Unlisted Shares in India
Learn how to invest in unlisted shares in India. Explore high-growth opportunities, understand risks, and discover proven strategies. Expert guide with step-by-step process.
